These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20432439)

  • 1. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
    Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
    J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands.
    Macoritto M; Nguyen-Yamamoto L; Huang DC; Samuel S; Yang XF; Wang TT; White JH; Kremer R
    J Biol Chem; 2008 Feb; 283(8):4943-56. PubMed ID: 18003614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bile acid-activated vitamin D receptor signaling in human hepatocytes.
    Han S; Li T; Ellis E; Strom S; Chiang JY
    Mol Endocrinol; 2010 Jun; 24(6):1151-64. PubMed ID: 20371703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
    J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.
    Jusu S; Presley JF; Kremer R
    J Biol Chem; 2017 Jan; 292(4):1490-1509. PubMed ID: 27852823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
    Wu W; Zhang X; Zanello LP
    Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
    Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
    J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
    Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
    J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol esters enhance 1α,25-dihydroxyvitamin D3-regulated 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) gene expression through ERK-mediated phosphorylation of specific protein 3 (Sp3) in Caco-2 cells.
    Jiang Y; Fleet JC
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):31-9. PubMed ID: 22871965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of VDR/RXR/DRIP205 Interaction, Intranuclear Localization, and DNA Binding in Ras-Transformed Keratinocytes and Its Implication for Designing Optimal Vitamin D Therapy in Cancer.
    Jusu S; Presley JF; Williams C; Das SK; Jean-Claude B; Kremer R
    Endocrinology; 2018 Mar; 159(3):1303-1327. PubMed ID: 29300860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription.
    Ellison TI; Dowd DR; MacDonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2309-19. PubMed ID: 15919723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
    Barletta F; Freedman LP; Christakos S
    Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.